Albumin-based nanoparticles as magnetic resonance contrast agents: I. Concept, first syntheses and characterisation

Histochemistry and Cell Biology

Volumn 133, Issue 4, 2010, Pages 375-404

  Stollenwerk, M M ^a   Pashkunova Martic, I ^b   Kremser, C ^c   Talasz, H ^c   Thurner, G C ^c   Abdelmoez, A A ^c,e   Wallnofer E A ^c   Helbok, A ^c   Neuhauser, E ^c   Klammsteiner, N ^c   Klimaschewski, L ^c   Von Guggenberg, E ^c   Frohlich E ^d   Keppler, B ^b   Jaschke, W ^c   Debbage, P ^c  

^a MALMÖ UNIVERSITY   (Sweden)

^b UNIVERSITY OF VIENNA   (Austria)

^c INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^d Center for Medical Research   (Austria)

^e ASSIUT UNIVERSITY   (Egypt)

Author keywords

Chelate; Contrast medium; Gadolinium; Human serum albumin; MRI; Nanoparticles

Indexed keywords

ALBUMIN; NANOMATERIAL; NANOPARTICLE;

ARTICLE; CHEMICAL ANALYSIS; CHEMICAL STRUCTURE; CYTOTOXICITY; FAST PROTEIN LIQUID CHROMATOGRAPHY; FREEZE DRYING; GEL PERMEATION CHROMATOGRAPHY; HUMAN; IMMUNOGENICITY; IMMUNOHISTOCHEMISTRY; MOLECULAR IMAGING; MORPHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PARTICLE SIZE; PHOTON CORRELATION SPECTROSCOPY; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; PROTEIN CONTENT; PURIFICATION; TRANSMISSION ELECTRON MICROSCOPY; TURBULENT FLOW; ZETA POTENTIAL;

ALBUMINS; CONTRAST MEDIA; GADOLINIUM; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MICROSCOPY, ELECTRON, TRANSMISSION; NANOPARTICLES; PARTICLE SIZE;

EID: 77952238403     PISSN: 09486143     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00418-010-0676-z     Document Type: Article

References (142)

1. F Alber S Dokudovskaya LM Veenhoff W Zhang J Kipper D Devos A Suprapto O Karni-Schmidt R Williams BT Chait MP Rout A Sali 2007 Determining the architectures of macromolecular assemblies Nature 450 683 694 1:CAS:528:DC%2BD2sXhtlKmtbzP 18046405 (Pubitemid 350207700)
2. F Alber S Dokudovskaya LM Veenhoff W Zhang J Kipper D Devos A Suprapto O Karni-Schmidt R Williams BT Chait A Sali MP Rout 2007 The molecular architecture of the nuclear pore complex Nature 450 695 701 1:CAS:528:DC%2BD2sXhtlKmtbzI 18046406 (Pubitemid 350207701)
3. WT Andersen-Berg M Strand TE Lempert AE Rosenbaum PM Joseph 1986 Nuclear magnetic resonance and gamma camera tumor imaging using gadolinium-labeled monoclonal antibodies J Nucl Medicine 27 829 833 (Pubitemid 17022673)
4. SA Anderson RK Rader WF Westlin C Null D Jackson GM Lanza SA Wickline JJ Kotyk 2000 Magnetic resonance contrast enhancement of neovasculature with alpha(v)beta(3)-targeted nanoparticles Magn Reson Med 44 433 439 1:STN:280:DC%2BD3cvpslWgtQ%3D%3D 10975896
5. Y Arano T Uezono H Akizawa M Ono K Wakisaka M Nakayama H Sakahara J Konishi A Yokoyama 1996 Reassessment of diethylenetriaminepentaacetic acid (DTPA) as a chelating agent for indium-111 labeling of polypeptides using a newly synthesized monoreactive DTPA derivative J Med Chem 39 3451 3460 1:CAS:528:DyaK28XkvVelsrw%3D 8784442 (Pubitemid 26307849)
6. AN Baranov IM Vlasova AM Saletskii 2004 Investigation of serum-albumin aggregation J Appl Spectroscopy 71 222 226 1:CAS:528:DC%2BD2cXltFWmsbg%3D (Pubitemid 38814103)
7. GM Barratt 2000 Therapeutic applications of colloidal drug carriers Pharm Sci Technol Today 3 163 171 1:CAS:528:DC%2BD3cXjtVCitbg%3D 10785658
8. DV Bazile C Ropert P Huve T Verrecchia M Marlard A Frydman M Veillard G Spenlehauer 1992 Body distribution of fully biodegradable [14C]-poly(lactic acid) nanoparticles coated with albumin after parenteral administration to rats Biomaterials 13 1093 1102 1:CAS:528:DyaK3sXhsFChur0%3D 1493193 (Pubitemid 23022908)
9. PQ Behrens AM Spiekerman JR Brown 1975 Structure of human serum albumin Fed Proc Fed Am Soc Exp Biol 34 591 abstr. 2106
10. MJ Blanco-Prieto MA Campanero K Besseghir F Heimgartner B Gander 2004 Importance of single or blended polymer types for controlled in vitro release and plasma levels of a somatostatin analogue entrapped in PLA/PLGA microspheres J Control Release 96 437 448 1:CAS:528:DC%2BD2cXjsFOltL8%3D 15120900 (Pubitemid 38553922)
11. Boisseau P, Kiparissides C, Pavesio A, Saxl O, Ambrosio L, Benninghofen A, Bigay C-N, Borros S, Briel A, Bruce D, Chabbal J, Charbit F, Coche T, Deacon J, Debbage P, Eaton M, Fuchs H, Fuhr G, Goossens J, Guenther R, Hawlina M, Hofmeister A, Kasemo B, Kirkpatrick J, Kuhn MH, Marche P, Meisel HJ, Mestais C, Moore R, Ogorevc B, Peponnet C, Pieber T, Pirovano D, Puget P, Reinmann M, Riese J, Rodriguez JR, Samitier J, Scherfler H, Schild C, Schmidt S, Schreder S, Souquet J, Subramaniam V, Tavitian B, Venturini P, Vericat JA, von Bally G, Weltring K-M, Williams D, Zivin M (2006) European technology platform on nanomedicine: nanotechnology for health-strategic research agenda. European Commission, Office for Official Publications of the European Communities (Luxembourg), 39 p. ISBN 92-79-02203-2
12. F Boury H Marchais JE Proust JP Benoit 1997 Bovine serum albumin release from poly(α-hydroxy acid) microspheres: effects of polymer molecular weight and surface properties J Control Release 45 75 86 1:CAS:528: DyaK28XntlOgsLs%3D (Pubitemid 27055795)
13. RC Brasch 1991 Rationale and applications for macromolecular Gd-based contrast agents Magn Reson Med 22 282 287 1:CAS:528:DyaK38XhsVKrsL0%3D 1725917
14. DR Broome MS Girguis PW Baron AC Cottrell I Kjellin GA Kirk 2007 Gadodiamide-associated nephrogenic systemic fibrosis: why radiologists should be concerned Am J Roentgenol 188 586 592 (Pubitemid 46167763)
15. JR Brown 1975 Structure of bovine serum albumin Fed Proc 34 591
16. DC Carter JX Ho 1994 Structure of serum albumin Adv Protein Chem 45 153 203 1:CAS:528:DyaK2cXltVajtLk%3D 8154369
17. EL Chang BP Gaber JP Sheridan 1982 Photon correlation spectroscopy study on the stability of small unilamellar DPPC vesicles Biophys J 39 197 201 1:CAS:528:DyaL38Xlt1antLY%3D 6896833
18. Chu B (1974) Laser light scattering. Academic Press Inc, New York
19. B Chu E Gulari E Gulari 1979 Photon correlation measurements of colloidal size distributions. II. Details of histogram approach and comparison of methods of data analysis Physica Script 19 476 485 1:CAS:528:DyaE1MXksFOlu7w%3D
20. VTG Chuang M Otagiri 2007 Recombinant human serum albumin Drugs Today 43 547 561 1:CAS:528:DC%2BD2sXhtFyjtLfO 17925886 (Pubitemid 47529738)
21. Cochrane Injuries Group Albumin Reviewers 1998 Human albumin administration in critically ill patients: systematic review of randomised controlled trials BMJ 317 235 240 (Pubitemid 28334148)
22. K Colgan ML Moody K Witte 2000 Responsible use of blood products in response to supply and demand Am J Health System Pharm 57 2094 2098 1:STN:280:DC%2BD3MzgtlCltA%3D%3D
23. TA Collidge PC Thomson PB Mark JP Traynor AG Jardine STW Morris K Simpson GH Roditi 2007 Gadolinium-enhanced MR imaging and nephrogenic systemic fibrosis: retrospective study of a renal replacement therapy cohort Radiology 245 168 175 17704357 (Pubitemid 47417800)
24. MS Cooper E Sabbah SJ Mather 2006 Conjugation of chelating agents to proteins and radiolabeling with trivalent metallic isotopes Nat Protoc 1 314 317 1:CAS:528:DC%2BD28XhtFOitbjO 17406251
25. DP Cormode T Skajaa ZA Fayad WJM Mulder 2009 Nanotechnology in medical imaging: probe design and applications J Am Heart Assoc 29 992 1000 1:CAS:528:DC%2BD1MXntVymt7k%3D
26. SE Cowper HS Robin SM Steinberg LD Su S Gupta PE LeBoit 2000 Scleromyxoedema-like cutaneous diseases in renal-dialysis patients Lancet 356 1000 1001 1:STN:280:DC%2BD3cvptVWgsw%3D%3D 11041404
27. SE Cowper PH Kuo R Bucala 2007 Nephrogeneic systemic fibrosis and gadolinium exposure: association and lessons for idiopathic fibrosing disorders Arthritis Rheum 56 3173 3175 1:CAS:528:DC%2BD2sXht12rtLjJ 17907160 (Pubitemid 47585409)
28. JM Cregg JL Cereghino J Shi DR Higgins 2000 Recombinant protein expression in Pichia pastoris Mol Biotechnol 16 23 52 1:CAS:528: DC%2BD3cXot1agtLk%3D 11098467
29. S Curry H Mandelkow P Brick N Franks 1998 Crystal structure of human serum albumin complexed with fatty acid reveals an asymmetric distribution of binding sites Nature Struct Biol 5 827 835 1:CAS:528:DyaK1cXlvVyhs7w%3D 9731778 (Pubitemid 28402087)
30. S Curry P Brick NP Franks 1999 Fatty acid binding to human serum albumin: new insights from crystallographic studies Biochem Biophys Acta 1441 131 140 1:CAS:528:DyaK1MXns1Sgs7Y%3D 10570241 (Pubitemid 29537733)
31. HE Daldrup-Link RC Brasch 2003 Macromolecular contrast agents for MR mammography: current status Eur Radiol 13 354 365 12599002
32. P Debbage 2009 Targeted drugs and nanomedicine: present and future Curr Pharm Des 15 153 172 1:CAS:528:DC%2BD1MXjvVOmsro%3D 19149610
33. P Debbage W Jaschke 2008 Molecular imaging with nanoparticles: giant roles for dwarf actors Histochem Cell Biol 130 845 875 1:CAS:528: DC%2BD1cXht1eit7zJ 18825403
34. A Donev FH Stillinger PM Chaikin S Torquato 2004 Unusually dense crystal ellipsoid packings Phys Rev Lett 92 1 255506
35. A Dugiaczyk SW Law OE Dennison 1982 Nucleotide sequence and the encoded amino acids of human serum albumin mRNA Proc Natl Acad Sci USA 79 71 75
36. CJ Edgell CC McDonald JB Graham 1983 Permanent cell line expressing human factor VIII-related antigen established by hybridization Proc Natl Acad Sci USA 80 3734 3737 1:STN:280:DyaL3s3itFKksw%3D%3D 6407019
37. WS Enochs G Harsh F Hochberg R Weissleder 1999 Improved delineation of human brain tumors on MR images using a long-circulating, superparamagnetic iron oxide agent J Magn Reson Imaging 9 228 232 1:STN:280:DyaK1M7nsVKgtA%3D%3D 10077018 (Pubitemid 29115346)
38. BL Erstad 1996 Viral infectivity of albumin and plasma protein fraction Pharmacotherapy 16 996 1001 1:STN:280:DyaK2s7gtlGquw%3D%3D 8947970
39. A Farooki V Narra J Brown 2004 Gadofosveset Curr Opin Invest Drugs 5 967 976 1:CAS:528:DC%2BD2cXpsVSis7g%3D
40. KJ Fehske Muller We U Wollert 1981 The location of drug binding sites in human serum albumin Biochem Pharmacol 30 687 692 1:CAS:528:DyaL3MXksFKnsrY%3D 7018498 (Pubitemid 11146814)
41. S Finfer R Bellomo N Boyce J French J Myburgh R Norton 2004 The SAFE Study Investigators. A comparison of albumin and saline for fluid resuscitation in the intensive care unit N Eng J Med 350 2247 2256 1:CAS:528: DC%2BD2cXksVehs70%3D
42. S Flacke S Fischer MJ Scott RJ Fuhrhop JS Allen M McLean P Winter GA Sicard PJ Gaffney SA Wickline GM Lanza 2001 Novel contrast agent for molecular imaging of fibrin. Implications for detecting vulnerable plaques Circulation 104 1280 1285 1:CAS:528:DC%2BD3MXnsV2mt7c%3D 11551880
43. PG Frank EW Scott DS Park MP Lisanti 2003 Caveolin, caveolae, and endothelial cell function Arterioscler Thromb Vasc Biol 23 1161 1168 1:CAS:528:DC%2BD3sXltVGkurs%3D 12689915
44. T Frenzel P Lengsfeld H Schirmer J Hütter H-J Weinmann 2008 Stability of Gadolinium-based magnetic resonance imaging contrast agents in human serum at 37°C Invest Radiol 43 817 828 1:CAS:528:DC%2BD1cXhtlGmtLzN 19002053
45. BJ Frisken 2001 Revisiting the method of cumulants for the analysis of dynamic light-scattering data Appl Opt 40 4087 4091 1:STN:280: DC%2BD1c3gtFOntg%3D%3D 18360445
46. JM Gallo CT Hung DG Perrier 1984 Analysis of albumin microsphere preparation Int J Pharm 22 63 74 1:CAS:528:DyaL2MXltVyhsw%3D%3D
47. WA Gibby KA Gibby WA Gibby 2004 Comparison of Gd-DTPA-BMA (Omniscan) versus Gd-HP-DO3A (Pro-Hance) retention in human bone tissue by inductively coupled plasma atomic emission spectroscopy Invest Radiol 39 138 142 15076005
48. AR Goldfarb 1966 Heterogeneity of amino groups in proteins. I. Human serum albumin Biochemistry 5 2574 2578 1:CAS:528:DyaF28XksV2jsrg%3D 5968566
49. P Goldwasser J Feldman 1997 Association of serum albumin and mortality risk J Clin Epidemiol 50 693 703 1:STN:280:DyaK2szptlygsA%3D%3D 9250267
50. JH Goll GB Stock 1977 Determination by photon correlation spectroscopy of particle size distributions in lipid vesicle suspensions Biophys J 19 265 273 1:STN:280:DyaE2s3kt1yjtQ%3D%3D 890039
51. J Goll FD Carlson Y Barenholz BJ Litman TE Thompson 1982 Photon correlation spectroscopic study of the size distribution of phospholipid vesicles Biophys J 38 7 13 1:CAS:528:DyaL38XhslKmt7w%3D 7074200
52. Gonzalez ER, Kannewurf BS (1998) Clinical review of appropriate uses for albumin. US Pharmacist 23:HS15-HS26
53. WJ Gradishar S Tjulandin N Davidson H Shaw N Desai P Bhar, et al. 2005 Phase III trial of nanoparticle albumin bound paclitaxel compared with polyethylated castor oil-based paclitaxel in women with breast cancer J Clin Oncol 23 7794 7803 1:CAS:528:DC%2BD2MXht1Cqs7nK 16172456
54. MI Griffel BS Kaufman 1992 Pharmacology of colloids and crystalloids Crit Care Clin 8 235 253 1:STN:280:DyaK383jtleisQ%3D%3D 1568139
55. A Gururaj Rao MS Narasinga Rao 1983 Effect of sodium dodecyl sulphate on the high molecular weight protein fraction of mustard (Brassica juncea) and rapeseed (Brassica campestris) J Biosci 5 301 309 1:CAS:528:DyaL2cXhslSitbY%3D
56. A Harrison CA Walker KA Pereira D Parker L Royle K Pulukkody TJ Norman 1993 Hepato-biliary and renal excretion in mice of charged and neutral gadolinium complexes of cyclic tetra-aza-phosphinic and carboxylic acids Magn Reson Imaging 11 761 770 1:CAS:528:DyaK2cXktlSjsro%3D 8371632
57. Hauff P, Reinhardt M, Briel A, Debus N, Schirner M (2004) Molecular targeting of lymph nodes with l-Selectin ligand-specific US contrast agent: a feasibility study in mice and dogs. Radiology. doi: 10.1148/radiol.2313030425 (Pubitemid 38668081)
58. XM He DC Carter 1992 Atomic-structure and chemistry of human serum albumin Nature 358 209 215 1:CAS:528:DyaK38XlsVGmurg%3D 1630489
59. Hiemenz PC (1984) Distribution functions. In: Hiemenz PC (ed) Polymer chemistry: the basic concepts. Marcel Dekker, New York. ISBN 082477082X, pp 34ff
60. JX Ho EW Holowachuk EJ Norton PD Twigg DC Carter 1993 X-ray and primary structure of horse serum albumin (Equus caballus) at 0.27-nm resolution Eur J Biochem 215 205 212 1:CAS:528:DyaK3sXlsFCgtrs%3D 8344282
61. DJ Hoylman 1970 The densest lattice packing of tetrahedra Bull Am Math Soc 76 135 137
62. AI Ivanov EA Korolenko EV Korolik SP Firsov RG Zhbankov MK Marchewka H Ratajczak 2002 Chronic liver and renal diseases differently affect structure of human serum albumin Arch Biochem Biophys 408 69 77 1:CAS:528: DC%2BD38XpsFyisrY%3D 12485604
63. LO Johansson A Bjørnerud HK Ahlström DL Ladd DK Fujii 2001 A targeted contrast agent for magnetic resonance imaging of thrombus: implications of spatial resolution J Magn Res Imag 13 615 618 1:STN:280: DC%2BD3M7os1Cjsw%3D%3D
64. HW Kang L Josephson A Petrovsky R Weissleder A Bogdanov Jr 2002 Magnetic resonance imaging of inducible E-selectin expression in human endothelial cell culture Bioconjugate Chem 13 122 127 1:CAS:528:DC%2BD3MXpt1Cns7k%3D
65. A Khurana VM Runge M Narayanan JF Greene Jr AE Nickel 2007 Nephrogenic systemic fibrosis. A review of 6 cases temporally related to gadodiamide injection (Omniscan) Invest Radiol 42 139 145 17220732
66. CP King MD Li MD Bednarski 2002 Vascular-targeted molecular imaging using functionalized polymerized vesicles J Magn Res Imag 16 388 393
67. DE Koppel 1972 Analysis of macromolecular polydispersity in intensity correlation spectroscopy. The method of cumulants J Chem Phys 57 4814 4820 1:CAS:528:DyaE3sXitFyqtQ%3D%3D
68. U Kragh-Hansen 1981 Molecular aspects of ligand binding to serum albumin Pharmacol Rev 33 17 53 1:CAS:528:DyaL3MXlvVagsLs%3D 7027277
69. PA Kramer 1974 Albumin microspheres as vehicles for achieving specificity in drug delivery J Pharm Sci 63 1646 1647 1:CAS:528:DyaE2MXmsVCntQ%3D%3D 4436811
70. J Künnemeyer L Terborg S Nowak L Telgmann F Tokmak BK Krämer A Günsel GA Wiesmüller J Waldeck C Bremer U Karst 2009 Analysis of the contrast agent Magnevist and its transmetalation products in blood plasma by capillary electrophoresis/electrospray ionization time-of-flight mass spectrometry Anal Chem 81 3600 3607 19338293
71. PH Kuo E Kanal AK Abu-Alfa SE Cowper 2007 Gadolinium-based MR contrast agents and nephrogenic systemic fibrosis Radiology 242 647 649 17213364
72. K Langer S Balthasar V Vogel N Dinauer H von Briesen D Schubert 2003 Optimization of the preparation process for human serum albumin (HSA) nanoparticles Int J Pharm 257 169 180 1:CAS:528:DC%2BD3sXjtVems74%3D 12711172
73. RB Lauffer DJ Parmelee SU Dunham HS Ouellet RP Dolan S Witte TJ McMurry RC Walovitch 1998 MS-325: albumin-targeted contrast agent for MR angiography Radiology 207 529 538 1:STN:280:DyaK1c3jvVeltQ%3D%3D 9577506
74. x)A, a new MRI contrast agent targeted to inflammation Bioconjugate Chem 15 99 103 1:CAS:528: DC%2BD3sXpt1akurY%3D
75. S Laurent L Vander Elst RN Müller 2006 Comparative study of the physicochemical properties of six clinical low molecular weight gadolinium contrast agents Contrast Med Mol Imaging 1 128 137 1:CAS:528: DC%2BD28Xpt1ShsbY%3D
76. JD Lewis G Destito A Zijlstra MJ Gonzalez JP Quigley M Manchester H Stuhlmann 2006 Viral nanoparticles as tools for intravital vascular imaging Nat Med 12 354 360 1:CAS:528:DC%2BD28XitVGnt7Y%3D 16501571
77. L Liang PC D'Haese LV Lamberts FL Van de Vyver ME De Broe 1991 Determination of gadolinium in biological materials using graphite furnace atomic absorption spectrometry with a tantalum boat after solvent extraction Anal Chem 63 423 427 1:CAS:528:DyaK3MXnslOqtg%3D%3D 2064008
78. W Lin AGA Coombes MC Davies SS Davis L Illum 1993 Preparation of sub-100 nm human serum albumin nanospheres using a pH-coacervation method J Drug Target 1 237 243 1:CAS:528:DyaK2cXit1KrsLo%3D 8069565
79. AB MacAdam ZB Shafi SL James C Marriott GP Martin 1997 Preparation of hydrophobic and hydrophilic albumin microspheres and determination of surface carboxylic acid and amino residues Int J Pharm 151 47 55 1:CAS:528: DyaK2sXjvFGnt70%3D
80. JJ Marty RC Oppenheimer P Speiser 1978 Nanoparticles-a new colloidal drug delivery system Pharm Acta Helv 53 17 23 1:CAS:528:DyaE1cXhslOjt7k%3D 643885
81. B Meloun L Moravek V Kostka 1975 Complete amino acid sequence of human serum albumin FEBS Lett 58 134 137 1:CAS:528:DyaE28XhsVGh 1225573
82. M Merodio A Arnedo MJ Renedo JM Irache 2001 Ganciclovir-loaded albumin nanoparticles: characterization and in vitro release properties Eur J Pharm Sci 12 251 259 1:CAS:528:DC%2BD3cXoslGhtLc%3D 11113644
83. H Minkowski 1904 Dichteste gitterförmige Lagerung kongruenter Körper Nachr Aka Wiss Göttingen Math Phys Kl II 311 355
84. SM Moghimi AC Hunter JC Murray 2001 Long-circulating and target-specific nanoparticles: theory to practice Pharmacol Rev 53 283 318 1:CAS:528: DC%2BD3MXkt1Gnurc%3D 11356986
85. M-J Montisci G Giovannuci D Duchêne G Ponchel 2001 Covalent coupling of asparagus pea and tomato lectins to poly(lactide) microspheres Int J Pharm 215 153 161 1:CAS:528:DC%2BD3MXhsleltbc%3D 11250101
86. GM Müller H Leuenberger T Kissel 1996 Albumin nanospheres as carriers for passive drug targeting: an optimized manufacturing technique Pharm Res 13 32 37 8668675
87. OECD Joint Meeting of the Chemicals Committee, Working Party on Manufactured Nanomaterials (2008) Series on the safety of manufactured nanomaterials, No. 6. List of manufactured nanomaterials and list of endpoints for phase one of the OECD testing programme. ENV/JM/MONO(2008)13/REV. http://www.oecd.org/ehs. For updates see http://www.oecd.org/env/nanosafety
88. MD Ogan U Schmiedl ME Mosely W Grodd H Paajanen RC Brasch 1987 Albumin labeled with Gd-DTPA: an intravascular contrast-enhancing agent for magnetic resonance blood pool imaging: preparation and characterization Invest Radiol 22 665 671 1:CAS:528:DyaL2sXltlSjtLw%3D 3667174 (Pubitemid 17138432)
89. N Ostrowsky D Sornette P Parker ER Pike 1981 Exponential sampling method for light scattering polydispersity analysis Optica Acta 28 1059 1070
90. MJ Pallansch DR Briggs 1954 A study of the interaction of dodecyl sulfate with bovine serum albumin J Am Chem Soc 76 1396 1403 1:CAS:528: DyaG2cXjs1Sqsg%3D%3D
91. DJ Parmelee RC Walovitch HS Ouellet RB Lauffer 1997 Preclinical evaluation of the pharmacokinetics, biodistribution, and elimination of MS-325, a blood pool agent for magnetic resonance imaging Invest Radiol 32 741 747 1:CAS:528:DyaK2sXnvFGhtbk%3D 9406014
92. I Paschkunova-Martic C Kremser K Mistlberger N Shcherbakova H Dietrich H Talasz Y Zou B Hugl M Galanski E Sölder K Pfaller I Höliner W Buchberger B Keppler P Debbage 2005 Design, synthesis, physical and chemical characterization, and biological interactions of lectin-targeted latex nanoparticles bearing Gd-DTPA chelates: an exploration of magnetic resonance molecular imaging (MRMI) Histochem Cell Biol 123 283 301 1:CAS:528: DC%2BD2MXjs1Ols70%3D 15824918
93. T Peters Jr 1977 Serum albumin: recent progress in the understanding of its structure and biosynthesis Clin Chem 23 5 12 1:CAS:528:DyaE2sXosVOrsA%3D%3D 318940
94. T Peters Jr 1985 Serum albumin Adv Protein Chem 37 161 245 1:CAS:528:DyaL2MXmtV2js70%3D 3904348
95. Peters T Jr (1996) All about albumin: biochemistry, genetics and medical applications. Academic Press, San Diego
96. HA Peterson JF Foster 1965 The microheterogeneity of plasma albumins, II. Preparation and solubility properties of subfractions J Biol Chem 240 2503 2507
97. M Port J-M Idée C Medina C Robic M Sabatou C Corot 2008 Efficiency, thermodynamic and kinetic stability of marketed gadolinium chelates and their possible clinical consequences: a critical review Biometals 21 469 490 1:CAS:528:DC%2BD1cXnsFahs78%3D 18344005
98. A Preda M van Vliet GP Krestin RC Brasch CF van Dijke 2006 Magnetic resonance macromolecular agents for monitoring tumor microvessels and angiogenesis inhibition Invest Radiol 41 325 331 16481916
99. SW Provencher 1979 Inverse problems in polymer characterization: direct analysis of polydispersity with photon correlation spectroscopy Makromol Chem 180 201 209 1:CAS:528:DyaE1MXnt1Gkug%3D%3D
100. Putnam FW (1984) The plasma proteins, vol 4, 2nd edn. Academic Press, London
101. ML Quillin BW Matthews 2000 Accurate calculation of the density of proteins Acta Cryst D56 791 794 1:CAS:528:DC%2BD3cXkvFCis7g%3D
102. Rainey TG, Read CA (1994) The pharmacological approach to the critically ill patient, 3rd edn. Williams & Wilkins, Baltimore, pp 272-290
103. Reid C (1996) Hilbert. Copernicus Books, New York, 228 p. ISBN 0-387-94674-8
104. G Riess 2003 Micellization of block copolymers Prog Polym Sci 28 1107 1170 1:CAS:528:DC%2BD3sXjvVCnsbw%3D
105. PA Rinck 2008 Radiologists meet with heavy collateral damage Diagn Imaging Europe Nov 2008 19 22
106. J Ring K Messmer 1977 Incidence and severity of anaphylactoid reactions to colloid volume substitutes Lancet 1 466 469 1:STN:280:DyaE2s7it1Ohuw%3D%3D 65572
107. JS Roberts SL Bratton 1998 Colloid volume expanders: problems, pitfalls and possibilities Drugs 55 621 630 1:STN:280:DyaK1c3ks12msA%3D%3D 9585860
108. NM Rofsky AD Sherry RE Lenkinski 2008 Nephrogenic systemic fibrosis: a chemical perspective Radiology 247 608 612 18487530
109. Rowe D, Gray JJ (2000) The Hilbert challenge. Oxford University Press, London, 315 p. ISBN 0-19-850651-1
110. EA Sadowski LK Bennett MR Chan AL Wentland AL Garrett RW Garrett A Djamali 2007 Nephrogenic systemic fibrosis: risk factors and incidence estimation Radiology 243 148 157 17267695
111. U Schmiedl M Ogan H Paajanen M Marotti LE Crooks AC Brito RC Brasch 1987 Albumin labeled with Gd-DTPA as an intravascular, blood pool-enhancing agent for MR imaging: biodistribution and imaging studies Radiology 162 205 210 1:CAS:528:DyaL2sXhsFahsbo%3D 3786763 (Pubitemid 17001811)
112. E Seneterre P Taourel Y Bouvier J Pradel B Van Beers J-P Daures J Pringot D Mathieu J-M Bruel 1996 Detection of hepatic metastases: ferumoxides-enhanced MR imaging versus unenhanced MR imaging and CT during arterial portography Radiology 200 785 792 1:STN:280:DyaK28zkslymsA%3D%3D 8756932
113. D Shahbazi-Gahrouei M Williams BJ Allen 2001 Synthesis and application of Gd-porphyrins as MR imaging agent for cancer detection Iran Biomed J 5 87 95 1:CAS:528:DC%2BD38XjvFCht7k%3D
114. D Shahbazi-Gahrouei M Roufeh MB Tavakoli 2006 Gadolinium- diethylenetriaminepenta-acetic acid conjugated with monoclonal antibody C595 as new magnetic resonance imaging contrast agents for breast cancer (MCF-7) detection Iran Biomed J 10 209 213 1:CAS:528:DC%2BD2sXitlCitbs%3D
115. MG Shapiro T Atanasijevic H Faas GG Westmeyer A Gasanoff 2006 Dynamic imaging with MRI contrast agents: quantitative considerations Magn Reson Imaging 24 449 462 1:CAS:528:DC%2BD28XktVyjur0%3D 16677952
116. A Singh T Patel J Hertel M Bernardo A Kausz L Brenner 2008 Safety of ferumoxytol in patients with anemia and CKD Am J Kidney Dis 52 907 915 1:CAS:528:DC%2BD1cXhsVarsbzO 18824288
117. DA Sipkins DA Cheresh MR Kazemi LM Nevin MD Bednarski KC Li 1998 Detection of tumor angiogenesis in vivo by alphaVbeta3-targeted magnetic resonance imaging Nat Med 4 623 626 1:CAS:528:DyaK1cXjtFKgtr4%3D 9585240
118. E Soelder C Kremser I Rohr P Hutzler P Debbage 2009 Molecular mapping deep within a living human organ: analysis of microvessel function on the timescale of seconds and with sub-micrometre spatial resolution Histochem Cell Biol 131 537 551 1:CAS:528:DC%2BD1MXjvVWgtbc%3D
119. I Soriano M Llabres C Evora 1995 Release control of albumin from polylactic acid microspheres Int J Pharm 125 223 230 1:CAS:528: DyaK2MXoslGmsLY%3D
120. AA Spector 1975 Fatty acid binding to plasma albumin J Lipid Res 16 165 179 1:CAS:528:DyaE2MXktVamsb0%3D 236351
121. G Stehle H Sinn A Wunder HH Schrenk S Schütt W Maier-Borst DL Heene 1997 The loading rate determines tumor targeting properties of methotrexate-albumin conjugates in rats Anti-Cancer Drugs 8 677 685 1:CAS:528:DyaK2sXmvFSis7g%3D 9311444
122. AJ Stewart CA Blindauer S Berezenko D Sleep PJ Sadler 2003 Interdomain zinc site on human albumin Proc Natl Acad Sci USA 100 3701 3706 1:CAS:528:DC%2BD3sXivFSqsLg%3D 12598656
123. S Sugio A Kashima S Mochizuki M Noda K Kobayashi 1999 Crystal structure of human serum albumin at 2.5 Å resolution Protein Eng 12 439 446 1:CAS:528:DyaK1MXkslGhsb4%3D 10388840
124. E Tabor 1999 The epidemiology of virus transmission by plasma derivatives: clinical studies verifying the lack of transmission of hepatitis B and C viruses and HIV type 1 Transfusion 39 1160 1168 1:STN:280: DC%2BD3c%2FmslOgsg%3D%3D 10604241
125. The Albumin Reviewers, Alderson P, Bunn F, Li Wan Po A, Li L, Roberts I, Schierhout G (2004) Human albumin solution for resuscitation and volume expansion in critically ill patients. The Cochrane Database of Systematic Reviews 2004, Issue 4. Art. No. CD001208.pub2. doi: 10.1002/14651858.CD001208. pub2
126. Tomlinson E, Burger JJ (1995) Incorporation of water soluble drugs in albumin microspheres. In: Widder KJ, Green R (eds) Part A: drug and enzyme targeting. Methods in enzymology, vol 112, Academic Press, London, pp 27-43
127. VP Torchilin 2002 PEG-based micelles as carriers of contrast agents for different imaging modalities Adv Drug Deliv Rev 54 235 252 1:CAS:528: DC%2BD38XhvVWnsr0%3D 11897148
128. S Torquato Y Jiao 2009 Dense packings of the Platonic and Archimedean solids Nature 460 876 879 1:CAS:528:DC%2BD1MXpvFCkt70%3D 19675649
129. MF Tweedle 1992 Physicochemical properties of gadoteridol and other magnetic resonance contrast agents Invest Radiol 27 Suppl 1 S2 S6 1506149
130. EC Unger WG Totty FL Otsuka WA Murphy MS Welch JM Connett GW Philpott 1985 Magnetic resonance imaging using gadolinium-labeled monoclonal antibody Invest Radiol 20 693 700 1:CAS:528:DyaL2MXlvFamu7k%3D 4066240
131. RE Unger V Krump-Konvalinkova K Peters CJ Kirkpatrick 2002 In vitro expression of the endothelial phenotype: comparative study of primary isolated cells and cell lines, including the novel cell line HPMEC-ST1.6R Microvasc Res 64 384 397 1:CAS:528:DC%2BD38XoslSntL0%3D 12453433
132. T Verrecchia P Huve D Bazile M Veillard G Spenlehauer P Couvreur 1993 Adsorption/desorption of human serum albumin at the surface of poly(lactic acid) nanoparticles prepared by a solvent evaporation process J Biomed Mater Res 27 1019 1028 1:CAS:528:DyaK2cXhtFKlt7c%3D 8408114
133. V Vogel K Langer S Balthasar P Schuck W Mächtle W Haase JA van den Broek C Tziatzios D Schubert 2002 Characterization of serum albumin nanoparticles by sedimentation velocity analysis and electron microscopy Progr Colloid Polym Sci 119 31 36 1:CAS:528:DC%2BD38Xhtl2kurw%3D
134. C Weber C Coester J Kreuter K Langer 2000 Desolvation process and surface characterisation of protein nanoparticles Int J Pharm 194 91 102 1:CAS:528:DyaK1MXnvFSlsbY%3D 10601688
135. C Weber S Reiss K Langer 2000 Preparation of surface modified protein nanoparticles by introduction of sulfhydryl troups Int J Pharm 211 67 78 1:CAS:528:DC%2BD3MXosl2htQ%3D%3D 11137340
136. P Wedeking K Kumar MF Tweedle 1992 Dissociation of gadolinium chelates in mice: relationship to chemical characteristics Mag Reson Imaging 10 641 648 1:CAS:528:DyaK3sXlsFahtg%3D%3D
137. H Weyl 1944 David Hilbert and his mathematical work Bull Am Math Soc 50 612 654
138. GW White WA Gibby MF Tweedle 2006 Comparison of Gd(DTPA-BMA) (Omniscan) versus Gd(HP-DO3A) (ProHance) relative to gadolinium retention in human bone tissue by inductively coupled mass spectroscopy Invest Radiol 41 272 278 16481910
139. MM Wilkes RJ Navickis 2001 Patient survival after human albumin administration. A meta-analysis of randomized, controlled trials Ann Intern Med 135 149 164 1:CAS:528:DC%2BD3MXmtlWktr8%3D 11487482
140. 3-integrin-targeted nanoparticles Circulation 108 2270 2274 1:CAS:528:DC%2BD3sXosVShs7c%3D 14557370
141. Yaxley PE (2009) Review of the human albumin controversy. Michigan Veterinary Conference, 22-25.01.2009
142. F Yuan 1998 Transvascular drug delivery in solid tumors Semin Radiat Oncol 8 164 175 1:STN:280:DyaK1c3pvVemug%3D%3D 9634493 (Pubitemid 28323475)